期刊书目 › CLINICAL NEUROLOGY(临床神经病学) › ESCI期刊Neuro-Oncology Advances 2024/2025影响因子:3.794 (NEURO-ONCOL ADV) (NULL). (CLINICAL NEUROLOGY)(临床神经病学)Emerging Source

Rheumatologist 发表于 2025-3-27 00:03:28

Submitted on: 20 April 2020.
Revised on: 17 May 2020.
Accepted on: 13 June 2020.
NULL

Nonconformist 发表于 2025-3-27 04:53:53

http://reply.papertrans.cn/3/230/22966/22966-32.png

褪色 发表于 2025-3-27 05:29:30

http://reply.papertrans.cn/3/230/22966/22966-33.png

Incisor 发表于 2025-3-27 11:08:04

http://reply.papertrans.cn/3/230/22966/22966-34.png

conduct 发表于 2025-3-27 13:55:00

http://reply.papertrans.cn/3/230/22966/22966-35.png

NADIR 发表于 2025-3-27 20:53:57

Submitted on: 05 November 2015.
Revised on: 17 December 2015.
Accepted on: 30 December 2015.
NULL

查看完整版本: ESCI期刊Neuro-Oncology Advances 2024/2025影响因子:3.794 (NEURO-ONCOL ADV) (NULL). (CLINICAL NEUROLOGY)(临床神经病学)Emerging Source